RAPT Therapeutics Inc (RAPT)
8.33
+0.20
(+2.46%)
USD |
NASDAQ |
May 03, 16:00
8.33
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Cash and Short Term Investments (Quarterly): 158.86M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 158.86M |
| September 30, 2023 | 184.78M |
| June 30, 2023 | 205.00M |
| March 31, 2023 | 231.63M |
| December 31, 2022 | 249.07M |
| September 30, 2022 | 195.44M |
| June 30, 2022 | 207.34M |
| March 31, 2022 | 173.01M |
| December 31, 2021 | 189.65M |
| September 30, 2021 | 210.79M |
| June 30, 2021 | 223.30M |
| Date | Value |
|---|---|
| March 31, 2021 | 98.41M |
| December 31, 2020 | 111.51M |
| September 30, 2020 | 122.79M |
| June 30, 2020 | 132.95M |
| March 31, 2020 | 138.20M |
| December 31, 2019 | 77.38M |
| September 30, 2019 | 48.31M |
| June 30, 2019 | 59.86M |
| March 31, 2019 | 61.76M |
| December 31, 2018 | 63.80M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
48.31M
Minimum
Sep 2019
249.07M
Maximum
Dec 2022
158.86M
Average
173.01M
Median
Mar 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 111.70M |
| Avinger Inc | 5.275M |
| Tonix Pharmaceuticals Holding Corp | 24.95M |
| Skye Bioscience Inc | 1.256M |
| Axsome Therapeutics Inc | 386.19M |